How business units get involved with J&J’s network of innovation centers

By Amy Lucas, Contributing Writer

How do innovation teams build constructive working relationships with the business units?

That’s the focus of our forthcoming research report, out later this month. And among the people we sought out for advice was Darren Snellgrove, Chief Financial Officer for Johnson & Johnson’s network of innovation centers. The centers aim to be an interface between J&J’s various business units — including pharmaceuticals, medical devices, and consumer healthcare — and the world of startups and academic research institutions. The goal is to spark new collaborations, and sometimes investments, that will lead to new products that J&J can deliver to patients.

• • •

What we do

J&J has 3 sectors: pharmaceutical, medical device, and consumer, and the innovation centers are one of the few places where those three sectors come together. At J&J Innovation, we’ve invested in some exciting areas across all three sectors and we’re seeing a lot more convergence. General areas of investment include; immuno-oncology, robotic surgery, 3D-printing, gene therapy, the microbiome, wearable technologies, and light therapy for aging and acne. The consumerization of healthcare and the wearable space will have a big impact on healthcare. Wearables, for example, can provide diagnostic capability, continuous monitoring, caregiver interaction, and increased patient and physician interaction.

Promo Text Under Gated Posts


Learn more about Innovation Leader

We’d love to show you around Innovation Leader and discuss how our research, articles, case studies, live events, conference calls, and other resources can help you and your corporate innovation team.
Complete the form at right or email
Already a member? Sign in here »       Got questions? Call us at (855) 585-0800 or Email us »